The effects of trazodone with L-tryptophan on sleep-disordered breathing in the English bulldog

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 5 I, 1999, Pages 1659-1667

  Veasey, Sigrid C ^a   Fenik, Polina ^b   Panckeri, Karen ^b   Pack, Allan I ^b   Hendricks, Joan C ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRAZODONE; TRYPTOPHAN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; ELECTROMYOGRAPHY; NONHUMAN; NONREM SLEEP; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SEROTONINERGIC SYSTEM; SLEEP APNEA SYNDROME;

EID: 0032697527     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.5.9812007     Document Type: Article

References (53)

1. Young, T., M. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr. 1993. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 328:1230-1235.
2. Gislason, T., B., Benediktsdottir, J. K. Bjornsson, G. Kjartansson, M. Kjeld, and H. Kristhjarnarson. 1993. Snoring, hypertension, and the sleep apnea syndrome: an epidemiological survey of middle-aged women. Chest 103:1147-1151.
3. He, J., M. H. Kryger, F. J. Zorick, W. Conway, and T. Roth. 1988. Mortality and apnea index in obstructive sleep apnea. Chest 94:9-14.
4. Sullivan, C. E., F. G. Issa, M. Berthon-Jones, and L. Eves. 1981. Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1:862-865.
5. Strohl, K. P., and S. Redline. 1986. Nasal CPAP therapy, upper airway muscle activation and obstructive sleep apnea. Am. Rev. Respir. Dis. 134:555-558.
6. Kribbs, N. B., A. I. Pack, L. R. Kline, P. L. Smith, A. R. Schwartz, N. M. Schubert, S. Redline, J. N. Henry, J. E. Getsy, and D. F. Dinges. 1993. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am. Rev. Respir. Dis. 147:887-895.
7. Levy, P., J. L. Pepin, P. Mayer, B. Wuyam, and D. Veale. 1996. Management of simple snoring, upper airway resistance syndrome, and moderate sleep apnea syndrome. Sleep 19(Suppl. 9):S101-S110.
8. Pepin, J. L., D. Veale, P. Mayer, G. Bettega, B. Wuyam, and P. Levy. 1996. Critictil analysis of the results of surgery in the treatment of snoring, airway resistance syndrome (UARS), and obstructive sleep apnea (OSA). Sleep 19(Suppl. 9):S90-S100.
9. Remmers, J. E., W. J. Degroot, E. K. Sauerland, and A. M. Anch. 1978. Pathogenesis of upper airway occlusion during sleep. J. Appl. Physiol. 44:931-938.
10. Berger, A. J., D. A. Bayliss, and F. Viana. 1992. Modulation of neonatal rat hypoglossal motoneuron excitability by serotonin. Neurosci. Lett. 143:164-168.
11. Bayliss, D. A., F. Viana, E. M. Talley, and A. J. Berger. 1997. Neuromodulation of hypoglossal motoneurons: cellular and developmental mechanisms. Respir. Physiol. 110:139-150.
12. Heym, J., G. F. Steinfels, and B. J. Jacobs. 1982. Activity of serotonin containing neurons in the nucleus pallidus of freely moving cats. Brain Res. 251:259-276.
13. Veasey, S. C., K. A. Panckeri, E. A. Hoffman, A. I. Pack, and J. C. Hendricks. 1996. The effects of serotonin antagonists in an animal model of sleep-disordered breathing. Am. J. Respir. Crit. Care Med. 153: 776-786.
14. Hendricks, J. C., L. R. Kline, R. J. Kovalski, J. A. O'Brien, A. R. Morrison, and A. I. Pack. 1987. The English bulldog: a natural model of sleep-disordered breathing. J. Appl. Physiol. 63:1344-1350.
15. Hendricks, J. C., B. J. Petrof, K. Panckeri, and A. I. Pack. 1993. Upper airway dilating muscle hyperactivity during non-rapid eye movement sleep in English bulldogs. Am. Rev. Respir. Dis. 148:185-194.
16. Schmidt, H. S. 1983. L-tryptophan in the treatment of impaired respiration in sleep. Bull. Eur. Physiopathol. Respir. 19:625-629.
17. Hanzel, D. A., N. G. Proia, and D. W. Hudgel. 1991. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 100:416-421.
18. Mendelson, W. B., M. Maczap, and J. Holt. 1991. Buspirone administration to sleep apnca patients. J. Clin. Psychopharmacol. 11:71-72.
19. Kraiczi, H., P. Dahlof, J. Carlson, H. Ejnell, and J. Hedner. 1997. Paroxetine reduces sleep disordered breathing in obstructive sleep (abstract). Am. J. Respir. Crit. Care Med. 155:A675.
20. Salazar-Grueso, H. F., R. S. Roenberg, and R. P. Roos. 1988. Sleep apnea in olivopontocerebellar degeneration: treatment with trazodone, Ann. Neurol. 23:399-401.
21. Wittig, R. M., A. Romaker, K. J. Zorick, T. A. Roehrs, W. A. Conway, and T. Roth. 1984. Night-to-night consistency of apneas during sleep. Am. Rev. Respir. Dis. 129:244-246.
22. Chediak, A. D., J. C. Acededo-Crespo, D. J. Seiden, H. H. Kim, and M. H. Kiel. 1996. Sleep disordered breathing: nightly variability in the indices of sleep-disordered breathing in men being evaluated for impotence with consecutive night polysomnograms. Sleep 19:589-592.
23. Schaechter, J. D., and R. J. Wurtman. 1990. Serotonin release varies with brain tryptophan levels. Brain Res. 532:203-210.
24. Kubin, L., H. Tojima, R. O. Davies, and A. I. Pack. 1992. Serotonergic excitatory drive to the hypoglossal motoneurons in the decerebrate cat. Neurosci. Lett. 139:243-248.
25. Ribeiro-do-Valle, L. E., C. E. Metzler, and B. L. Jacobs. 1991. Facilitation of masseter EMG and masseteric (jaw closure) reflex by serotonin in behaving cats. Brain Rev. 550:197-204.
26. Okabe, S., and L. Kubin. 1996. Role of 5-HTI receptors in the control of hypoglossal moloneurons in vivo. Sleep 19:S150-S153.
27. Maj, J., W. Palider, and A. Rawlow. 1993. Trazodone, a central serotonin antagonist and agonist. J. Neurol. Transm. 44:237-248.
28. Marek, G. J., C. J. McDougle, L. H. Price, and L. S. Seiden. 1992. A comparison of trazodonc and fluoxetine: implications for a serotoninergic mechanism of antidepressant action. Psychopharmacology 109:2-11.
29. Kennett, G. A., and G. Curzon. 1988. Evidence that m-CPP may have behavioral effects mediated by central 5-HTIC receptors. Br. J. Pharmacol. 94:137-147.
30. Ware, J. C., and J. T. Pittard. 1990. Increased deep sleep after trazodone use: a double-blind placebo-controlled study in healthy young animals. J. Clin. Psychiatry 51(Suppl. 9):18-22.
31. Hartmann, E., J. G. Lindsley, and C. Spinweber. 1983. Chronic insomnia: effects of tryptophan, flurazepam, secobarbital and placebo. Psychopharmacology 80:138-142.
32. Brooks, D., R. L. Horner, L. F. Kozar, C. L. Render-Teixeira, and E. A. Phillipson. 1997. Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J. Clin. Invest. 99:106-109.
33. Rechtschaffen, A., and A. Kales. 1968. A Manual of Standardizing Terminology: Techniques and Scoring System for Sleep Stages of Human Subjects. UCLA Brain Information Service, Brain Research Institute, Los Angeles.
34. Guilleminault, C., R. Stoohs, A. Clerk, J. Simmons, and M. Labanowski. 1992. From obstructive sleep apnea to upper airway resistance syndrome: consistency in daytime sleepiness. Sleep 15(Suppl. 6):S13-S16.
35. Berg, S., J. S. Haight, V. Yap, V. Hoffstein, and P. Cole. 1997. Comparison of direct and indirect measurements of respiratory airflow: implications for hypopneas. Sleep 20:60-64.
36. Hendricks, J. C., R. J. Kovalski, and L. R. Kline. 1993. Phasic respiratory muscle patterns and sleep-disordered breathing in the English bulldog. Am. Rev. Respir. Dis. 148:185-194.
37. Haponik, E. F., P. L. Smith, M. E. Boldman, R. P. Allen, S. M. Goldman, and E. R. Bleecker. 1983. Computerized tomography in obstructive sleep apnea: correlation of airway size with physiology during sleep and wakefulness. Am. Rev. Respir. Dis. 127:221-226.
38. Mezzanotte, W. S., D. J. Tangel, and D. P. White. 1992. Waking genioglossal electromyogram in sleep apnea patients versus normal controls: a neuromuscular compensatory mechanism. J. Clin. Invest. 89:1571-1579.
39. Jacobs, B. L., and C. A. Fornal. 1995. Serotonin and behavior: a general hypothesis. In F. R. Bloom and D. J. Kupfer, editors. Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York. 461-469.
40. Kubin, L., H. Tojima, C. Reignier, A. I. Pack, and R. O. Davies. 1996. Interaction of serotonergic excitatory drive to hypoglossal motoneurons with carbachol-induced REM sleep-like atonia. Sleep 19:187-195.
41. Lalley, P. M., R. Benacka, A. M. Bischoff, and D. W. Richter. 1997. Nucleus raphe obscurus evokes S-HT-1A receptor-mediated modulation of respiratory neurons. Brain Res. 747:156-159.
42. 4 receptors in the control of hypoglossal motoneurons in vivo. Sleep 19:S150-S153.
43. Okabe, S., M. Mackiewicz, and L. Kubin. 1997. Serotonin receptor mRNA expression in the hypoglossal motor nucleus. Respir. Physiol. 110:151-160.
44. Saudou, F., and R. Hen. 1994. 5-hydroxytryptomine receptor subtypes in vertebrates and invertebrates [Review]. Neurochem. Int. 25:503-532.
45. 4 receptors [Review]. Trends Pharmacol. Sci. 16:391-398.
46. 7 receptor: an orphan found. Trends Pharmacol. Sci. 18:104-107.
47. Arita, H., and M. Ochiishi. 1991. Opposing effects of 5-hydroxytryptamine on two types of medullary inspiratory neurons with distinct firing patterns. J. Neurophysiol. 66:285-292.
48. Lalley, P. M., A. M. Bischoff, S. W. Schwarzacher, and D. W. Richter. 1995. 5-HT2 receptor-controlled modulation of medullary respiratory neurones in the cat. J. Physiol. (Lond.) 487:653-661.
49. Fenik, V., L. Kuhin, S. Okabe, A. I. Pack, and R. O. Davies. 1997. Differential sensitivity of laryngeal and pharyngeal motoneurons to iontophoretic application of serotonin. Neuroscience 81:873-885.
50. Centers for Disease Control. 1989. Eosinophilia-Myalgia Syndrome: New Mexico. M.M.W.R. C.D.C. Surveill. Summ. 38:765-767.
51. Centers for Disease Control. 1989. Eosinophilia-Myalgia Syndrome associated with ingestion of L-tryptophan: United States. M.M.W.R. C.D.C. Surveill. Summ. 38:843.
52. Slutsker, L., F. C. Hoesly, L. Miller, P. Williams, J. C. Watson, and D. W. Fleming. 1990. Eosinophilia-Myalgia Syndrome associated with exposure to tryptophan from a single manufacturer. J.A.M.A. 264:213-217.
53. Sack, K. E., and L. A. Criswell. 1992. Eosinophilic Myalgia Syndrome: the aftermath. South. Med. J. 85:878-882.